Risk of Solid Organ Transplantation in Individuals With Celiac Disease: A Nationwide Cohort Study

John B Doyle1, Benjamin Lebwohl1, Jonas Soderling2

  • 1Division of Digestive and Liver Diseases, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York; Department of Medicine, Celiac Disease Center, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York.

Insights

Individuals with celiac disease (CeD) face a nearly threefold higher risk of requiring solid organ transplantation. This increased risk is particularly pronounced for liver transplantation, highlighting a significant association between CeD and severe organ disease.

Area of Science:

  • Gastroenterology and Hepatology
  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Celiac disease (CeD) is linked to chronic liver, kidney, and heart conditions.
  • The specific risk of severe organ disease necessitating transplantation in CeD patients remains unclear.

Purpose of the Study:

  • To quantify the risk of solid organ transplantation in individuals diagnosed with celiac disease.
  • To compare transplantation rates in CeD patients against the general population.

Main Methods:

  • A population-based matched cohort study was conducted in Sweden.
  • Individuals with biopsy-proven CeD (2000-2023) were identified via the ESPRESSO histopathology cohort.
  • Cox proportional hazards models were used to estimate the relative risk of solid organ transplantation (liver, heart, kidney, lung).

Main Results:

  • The study included 41,277 CeD patients and 196,863 matched controls.
  • CeD patients had a significantly higher incidence of solid organ transplantation (17.0 vs. 4.6 per 100,000 person-years).
  • An adjusted hazard ratio of 2.76 indicated a 2.76-fold increased risk of transplantation in CeD individuals, with significant risks for liver (HR 7.26) and kidney (HR 1.85) transplants.

Conclusions:

  • Celiac disease is associated with a substantially increased risk of requiring solid organ transplantation.
  • The risk is particularly elevated for liver transplantation, suggesting a strong link between CeD and end-stage liver disease.
  • Further investigation into the underlying pathophysiology connecting CeD and severe organ damage is warranted.
Abstract

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...